If offered an alternative GLP-1 brand or formulation, confirm with the prescribing doctor that it is appropriate for your condition, as these medications are not directly interchangeable without clinical assessment
Heterogeneous treatment effects of GLP-1RAs and SGLT2is on risk of Alzheimer's disease and related dementia in patients with type 2 diabetes: Insights from a real-world target trial emulation
Modest but progressive declines in Hb values were statistically significant in ill COVID-19 patients, and morphologically abnormal RBCs such as stomatocytes and knizocytes were observed in the blood of COVID-19 patients ( 2 transport and in thrombosis, the role of RBC mediator dysregulation in COVID-19 complications requires investigation, including study of interaction with the known dysregulation of banked RBCs
For patients with pre-existing mild or moderate DR, the effects of GLP-1 drugs could significantly worsen this condition
Other potential causes include infections, IBS, and inflammatory bowel diseases like Crohns disease and ulcerative colitis
